StockData
Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock

CRBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$3.01−0.37 (-10.81%)

Close on Nov 17, 2026Market cap $58.22MP/E –Yield –

Corbus Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Corbus Pharmaceuticals's total debt was $12.76M at Mar 31, 2024. For fiscal 2023 it was $15.91M, down 15.3% from the year before. The highest annual figure on record is $18.78M in fiscal 2022.

Annual total debt

PeriodPeriod endValueChange
FY2023Dec 31, 2023$15.91M-15.3%
FY2022Dec 31, 2022$18.78M+0.3%
FY2021Dec 31, 2021$18.73M+3.9%
FY2020Dec 31, 2020$18.03M–
FY2015Dec 31, 2015$0–
FY2014Dec 31, 2014$0-100.0%
FY2013Dec 31, 2013$331.24K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2024Mar 31, 2024$12.76M-32.7%
Q4 FY2023Dec 31, 2023$15.91M-15.3%
Q3 FY2023Sep 30, 2023$17.85M-7.4%
Q2 FY2023Jun 30, 2023$18.34M-3.9%
Q1 FY2023Mar 31, 2023$18.98M+0.4%
Q4 FY2022Dec 31, 2022$18.78M+0.3%
Q3 FY2022Sep 30, 2022$19.27M+3.9%
Q2 FY2022Jun 30, 2022$19.09M+3.9%
Q1 FY2022Mar 31, 2022$18.91M+3.9%
Q4 FY2021Dec 31, 2021$18.73M+3.9%
Q3 FY2021Sep 30, 2021$18.55M+3.9%
Q2 FY2021Jun 30, 2021$18.37M–
Q1 FY2021Mar 31, 2021$18.20M–
Q4 FY2020Dec 31, 2020$18.03M–
Q3 FY2020Sep 30, 2020$17.86M–

More Corbus Pharmaceuticals figures

See a number that looks wrong?